Question 1

Does BlackRock own TVTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BlackRock holds 8,020,663 shares of TVTX (Travere Therapeutics), worth $455.7M.

Question 2

How many shares of TVTX does BlackRock own?

Accepted Answer

As of its Q2 2026 13F, BlackRock holds 8,020,663 shares of TVTX (Travere Therapeutics).

Question 3

What is BlackRock's TVTX position worth?

Accepted Answer

As of its Q2 2026 13F, BlackRock's TVTX position is worth $455.7M.

Question 4

Is BlackRock buying or selling TVTX?

Accepted Answer

In Q2 2026, BlackRock increased its TVTX position by 228,630 shares (+2.9%).

Question 5

When did BlackRock first buy TVTX?

Accepted Answer

BlackRock already held TVTX in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	8M	+2.9%	$455.7M	0.0%	$56.81	32
2026-Q1	Decreased	7.8M	-1.0%	$231.5M	0.0%	$29.71	0
2025-Q4	Decreased	7.9M	-2.9%	$300.7M	0.0%	$38.21	0
2025-Q3	Decreased	8.1M	-0.8%	$193.6M	0.0%	$23.90	0
2025-Q2	Decreased	8.2M	-0.3%	$120.9M	0.0%	$14.80	0
2025-Q1	Increased	8.2M	+2.1%	$146.8M	0.0%	$17.92	31
2024-Q4	Increased	8M	+6.1%	$139.7M	0.0%	$17.42	32
2024-Q3	First report	7.6M	-	$105.7M	0.0%	$13.99	0

TVTX8 quarters

TVTX
8 quarters